7.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FGEN Giù?
Forum
Previsione
Precedente Chiudi:
$7.71
Aprire:
$7.57
Volume 24 ore:
5,265
Relative Volume:
0.13
Capitalizzazione di mercato:
$30.52M
Reddito:
$147.75M
Utile/perdita netta:
$-284.23M
Rapporto P/E:
-2.5768
EPS:
-2.93
Flusso di cassa netto:
$-317.54M
1 W Prestazione:
+0.40%
1M Prestazione:
+39.30%
6M Prestazione:
-40.34%
1 anno Prestazione:
-75.65%
Fibrogen Inc Stock (FGEN) Company Profile
Nome
Fibrogen Inc
Settore
Industria
Telefono
415-978-1200
Indirizzo
350 BAY STREET, SAN FRANCISCO, CA
Confronta FGEN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
FGEN
Fibrogen Inc
|
7.55 | 31.16M | 147.75M | -284.23M | -317.54M | -2.93 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-08-08 | Downgrade | BofA Securities | Neutral → Underperform |
2023-06-26 | Downgrade | BofA Securities | Buy → Neutral |
2023-06-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
2023-06-26 | Downgrade | Stifel | Buy → Hold |
2023-06-26 | Downgrade | William Blair | Outperform → Mkt Perform |
2023-06-02 | Aggiornamento | Stifel | Hold → Buy |
2023-01-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
2023-01-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
2023-01-05 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-09-22 | Downgrade | Goldman | Neutral → Sell |
2021-08-20 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
2021-07-16 | Downgrade | BofA Securities | Buy → Neutral |
2021-07-16 | Downgrade | Stifel | Buy → Hold |
2021-04-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
2021-04-07 | Downgrade | Mizuho | Buy → Neutral |
2021-03-31 | Aggiornamento | BofA Securities | Neutral → Buy |
2021-03-02 | Downgrade | Jefferies | Buy → Hold |
2021-02-01 | Iniziato | H.C. Wainwright | Buy |
2020-10-26 | Iniziato | Raymond James | Underperform |
2020-07-10 | Ripresa | Stifel | Buy |
2020-05-01 | Iniziato | Cowen | Market Perform |
2020-04-27 | Iniziato | BofA/Merrill | Neutral |
2019-05-29 | Ripresa | Goldman | Neutral |
2019-05-10 | Downgrade | William Blair | Outperform → Mkt Perform |
2019-04-12 | Iniziato | Piper Jaffray | Neutral |
2019-02-11 | Ripresa | Stifel | Buy |
2018-12-19 | Aggiornamento | Citigroup | Neutral → Buy |
2017-08-08 | Reiterato | Leerink Partners | Outperform |
2017-08-08 | Reiterato | Stifel | Buy |
2017-07-21 | Downgrade | Goldman | Buy → Neutral |
2017-07-11 | Iniziato | Jefferies | Buy |
2016-02-11 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2016-01-21 | Iniziato | Credit Suisse | Neutral |
2015-12-04 | Iniziato | Citigroup | Buy |
2015-09-23 | Iniziato | Lake Street | Hold |
2015-07-29 | Iniziato | Citigroup | Buy |
2015-07-20 | Aggiornamento | Goldman | Neutral → Buy |
2014-12-09 | Iniziato | Stifel | Buy |
Mostra tutto
Fibrogen Inc Borsa (FGEN) Ultime notizie
What analysts say about FibroGen Inc. stockTremendous return on equity - Autocar Professional
Is FibroGen Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com
FibroGen Inc. Stock Analysis and ForecastFastest return on investment - Autocar Professional
What drives FibroGen Inc. stock priceMarket-leading capital gains - Autocar Professional
40-Year Biotech Veteran Jim Schoeneck Joins Connect Biopharma Board as Asthma Drug Enters Critical Phase - Stock Titan
Why FibroGen Inc. stock attracts strong analyst attentionSafe and Smart Investment Picks - beatles.ru
What makes FibroGen Inc. stock price move sharplyFree Investment Community - Newser
How FibroGen Inc. stock performs during market volatilityParabolic Move Ideas - Newser
FibroGen amends financing agreement to reduce minimum cash balance requirement By Investing.com - Investing.com South Africa
FibroGen amends financing agreement to reduce minimum cash balance requirement - Investing.com Australia
FibroGen (FGEN) Trading Halted Pending News Release | FGEN Stock News - GuruFocus
FibroGen Enters New Agreement with HiFiBiO - TipRanks
Fibrogen IncOn June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio - MarketScreener
FibroGen (FGEN) Announces 1-for-25 Reverse Stock Split | FGEN St - GuruFocus
FibroGen to implement 1-for-25 reverse stock split; shares down 15% - MSN
Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
FibroGen Announces 1-for-25 Reverse Stock Split - The Manila Times
Adobe, RH And 3 Stocks To Watch Heading Into FridayAdobe (NASDAQ:ADBE), FibroGen (NASDAQ:FGEN) - Benzinga
FibroGen Announces 1-for-25 Reverse Stock Split | FGEN Stock New - GuruFocus
FibroGen Announces Reverse Stock Split Effective June 16 - TipRanks
FibroGen to Implement 1-for-25 Reverse Stock Split - marketscreener.com
FibroGen To Implement 1-for-25 Reverse Stock Split - Nasdaq
FibroGen, Inc. Announces 1-for-25 Reverse Stock Split Effective June 16, 2025 - Nasdaq
Fibrogen Announces 1-For-25 Reverse Stock Split - marketscreener.com
FibroGen's Massive 1-for-25 Reverse Split Cuts 101M Shares to 4MWhat Investors Must Know - Stock Titan
Millennium Management LLC Lowers Stock Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
FibroGen expands board with biotech veteran Kauffman By Investing.com - Investing.com South Africa
FibroGen expands board with biotech veteran Kauffman - Investing.com Australia
FibroGen Amends Financing Agreement for Flexibility - TipRanks
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors | FGEN Stock News - GuruFocus
Fibrogen Appoints Michael Kauffman To Its Board Of Directors - marketscreener.com
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors - GlobeNewswire
FibroGen Strengthens Board with Velcade Developer: Key Move for Pipeline Advancement - Stock Titan
Squarepoint Ops LLC Takes Position in FibroGen, Inc. (NASDAQ:FGEN) - Defense World
Fibrogen Inc Azioni (FGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):